Related Experiment Video
Updated: Jul 13, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
The apoptosome: emerging insights and new potential targets for drug design
Marcello D'Amelio1, Elisa Tino, Francesco Cecconi
1Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy.
Abstract:
Apoptosis plays a crucial role in tissue homeostasis, development and many diseases. The relevance of Apaf1, the molecular core of apoptosome, has been underlined in mitochondria-dependent apoptosis, which according to a growing body of evidence, is involved in various pathologies where the equilibrium of life-and-death is dysregulated, such as heart attack, stroke, liver failure, cancer and autoimmune diseases. Consequently, great interest has emerged in devising therapeutic strategies for regulating the key molecules involved in the life-and-death decision. Here we review recent progress in apoptosis-based pharmacological therapies and, in particular, we point out a possible role of the apoptosome as an emerging and promising pharmacological target.
Insights
Apoptosis regulates cell death and is crucial for health and disease. The apoptosome, a key player in apoptosis, is emerging as a promising target for new pharmacological therapies.
Area of Science:
- Cellular Biology
- Molecular Biology
- Pathology
Background:
- Apoptosis is vital for tissue homeostasis, development, and disease.
- Mitochondria-dependent apoptosis involves Apaf1, the core of the apoptosome.
- Dysregulated apoptosis contributes to various pathologies like heart attack, stroke, liver failure, cancer, and autoimmune diseases.
Purpose of the Study:
- To review recent advancements in apoptosis-based pharmacological therapies.
- To highlight the apoptosome as a potential therapeutic target.
Main Methods:
- Literature review of apoptosis-based pharmacological therapies.
- Analysis of the role of Apaf1 and the apoptosome in disease.
Main Results:
- Apaf1 is central to mitochondria-dependent apoptosis.
- The apoptosome is implicated in numerous diseases with dysregulated cell death.
- Emerging evidence supports the apoptosome as a viable pharmacological target.
Conclusions:
- Targeting the apoptosome offers a promising strategy for therapeutic intervention.
- Further research into apoptosis regulation can lead to novel treatments for various diseases.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

